Naveen Singh, PGDM Finance Batch 2012-2014
Naveen is currently working as a manager in deals practice in PwC Germany. He worked on a successful deal which got announced on 30th June 2021.
This is a healthcare sector deal, which became even more important during the pandemic.
Naveen and his PwC team worked closely with Orgentec’s management and their stakeholder Water Street Healthcare Partners, a strategic investor focused exclusively on healthcare and supported them with financial due diligence for their sales side.
Sebia, a leading provider of clinical protein electrophoresis equipment and reagents for diabetes and oncology detection, announced the acquisition on 30th June of specialty diagnostic leader ORGENTEC Diagnostika. The transaction is expected to close in the next quarter.
Based in Mainz, Germany, ORGENTEC Diagnostika is a world market leader in the development, production, and marketing of diagnostic tests to detect autoimmune and blood diagnostics and treatment-associated monitoring. Clinical areas include inflammatory rheumatic diseases, thrombosis diagnostics, blood diagnostics for the serological detection of autoimmune vasculitis, thyroid diagnostics, gastroenterology and diabetes diagnostics.
Suggested Links to read more about this deal –
https://www.prnewswire.com/news-releases/sebia-acquires-orgentec-diagnostika-301322729.html
https://www.pharmaceuticalcommerce.com/view/sebia-acquires-specialty-diagnostics-company-orgentec-diagnostika
